SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Zanganeh Maky

(Last) (First) (Middle)
C/O PHARMACYCLICS, INC.
995 EAST ARQUES AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PHARMACYCLICS INC [ PCYC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Operating Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/07/2014
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/07/2014 M 1,551 A $2.3 211,863 D
Common Stock 11/07/2014 S 1,551 D $135.01 210,312 D
Common Stock 11/10/2014 M 23,000 A $2.3 233,312 D
Common Stock 11/10/2014 S 3,000 D $133.5 230,312 D
Common Stock 11/10/2014 S 8,524 D $133.942 221,788 D
Common Stock 11/10/2014 S 5,000 D $133.7616 216,788 D
Common Stock 11/10/2014 S 6,476 D $133.8785 210,312 D
Common Stock 11/12/2014 M 5,931 A $7.19 216,243 D
Common Stock 11/12/2014 S 5,273 D $138.0127 210,970 D
Common Stock 11/12/2014 S 658 D $137.5 210,312 D
Common Stock 75,363 I Custodian(1)
Common Stock 900 I By Individual Retirement Account
Common Stock 725 I By Roth Individual Retirement Account
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $2.3 11/07/2014 M 1,551 09/10/2008(2) 09/10/2018 Common Stock 1,551 $0.00 71,219 D
Stock Option (Right to Buy) $2.3 11/10/2014 M 23,000 09/10/2008(2) 09/10/2018 Common Stock 23,000 $0.00 48,219 D
Stock Option (Right to Buy) $7.19 11/12/2014 M 5,931 04/11/2010(3) 04/11/2020 Common Stock 5,931 $0.00 144,069 D
Explanation of Responses:
1. Reporting Person as custodian for minor child.
2. Option granted under the issuer's 1995 Stock Option Plan in a transaction exempt under rule 16b-3(d). The option vested in forty-eight (48) equal and successive monthly installments. This option is fully vested.
3. Option granted under the issuer's 1995 Stock Option Plan in a transaction exempt under rule 16b-3(d). This option vested in four equal annual installments beginning April 11, 2011, subject to satisfaction of certain performance criteria with respect to each annual period. This option is fully vested.
Remarks:
/s/ Makham Zanganeh 11/12/2014
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.